Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/Waterbury
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Waterbury, CT

Studies commonly pay $75 to $4,500 per completed study

1,134 clinical trials are currently recruiting participants within 30 miles of Waterbury. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,134studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Waterbury right now

Top 25 of 1,134 recruiting studies, sorted by proximity — each links to its official registry page

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Midstate Medical Center (MSMC) — Meriden, Connecticut (11.9 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
Smilow Cancer Hospital (Yale University) — New Haven, Connecticut (18.2 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Yale University — New Haven, Connecticut (18.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Alcohol Use Disorder, Cannabis Use Disorder N/A Interventional 294 participants sought
UConn Health — Farmington, Connecticut (15.4 mi) · Sponsor: Massachusetts General Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06395467)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
DaVita Clinical Research — Middlebury, Connecticut (5.2 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (18.2 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Smilow Cancer Hospital-Waterbury Care Center — Waterbury, Connecticut (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Advanced Prostate Cancer, Metastatic Prostate Cancer Phase 1 Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (18.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05800665)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (18.2 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06538064)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (18.2 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Yale-New Haven Hospital — New Haven, Connecticut (18.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Advanced Solid Tumor Phase 1 Interventional 105 participants sought
Yale Cancer Center — New Haven, Connecticut (18.2 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT07226349)

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Solid Tumors, Sarcomas Phase 1 Interventional 180 participants sought
Zai Lab Site 02030 — New Haven, Connecticut (18.2 mi) · Sponsor: Zai Lab (Shanghai) Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07374848)

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection Recurrence Phase 2 Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (13.3 mi) · Sponsor: Acurx Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07513285)

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 3 Interventional 150 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (23.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT04844606)

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Pediatric Cancer N/A Observational 35 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (23.0 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06423950)

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

EGFR Inhibitor-associated Rash Phase 1, Phase 2 Interventional 32 participants sought
Yale University School of Medicine — New Haven, Connecticut (18.2 mi) · Sponsor: Azitra Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06830863)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — New Haven, Connecticut (18.2 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Nuvance Health- Danbury Hospital — Danbury, Connecticut (24.4 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Yale University School of Medicine — New Haven, Connecticut (18.2 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2 Interventional 40 participants sought
Uconn Health — Farmington, Connecticut (15.4 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07213973)

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

Cardiac Arrest N/A Observational 600 participants sought
Yale University — New Haven, Connecticut (18.2 mi) · Sponsor: Boston Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT03261089)
Actively enrolling

Studies you may be able to join near Waterbury

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Waterbury

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Chase Medical Research, LLC

★ 3.4
500 Chase Pkwy, Waterbury, CT 06708
(203) 419-4404
"Their purpose is to oversee medical research. I have completed two studies with them, and find their staff to be professionally competent and knowled…"
— Kenneth Roden, 5★

Cheshire Clinical Research Consultants

1030 S Main St #9, Cheshire, CT 06410
(203) 826-8831

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

CT Clinical Research

160 West St Ste 1A, Cromwell, CT 06416
(860) 632-0144

Medical Research Center of Connecticut

2200 Whitney Avenue Hamden Wallingford, Hamden, CT 06518
(203) 281-5161

Yale-Griffin Prevention Research Center

130 Division St, Derby, CT 06418
(203) 732-1265

Clinical Research Consulting LLC

★ 4.0
2080 Bridgeport Ave D, Milford, CT 06460
(203) 386-3115
"Just finishing up a research study with them, they are all very friendly and organized. They are efficient and do a good job of getting you in and ou…"
— Stephen Callahan, 5★

Pfizer New Haven Clinical Research Unit

★ 4.2
1 Howe St, New Haven, CT 06511
(800) 254-6398
"I had been doing studies here for some years and had a really bad experience with a doctor during screening. I think the dr was racist i don’t know b…"
— aster390, 1★

Research Center for Clinical Studies, Inc.

★ 5.0
71 East Ave, Norwalk, CT 06851
(203) 838-0070

Clinical trials in Waterbury: what's recruiting

The Waterbury area currently has 1,134 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Waterbury, the most active research areas are:

  • Cancer & Oncology12 studies
  • Liver & Kidney1 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Waterbury, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Waterbury

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Waterbury participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Waterbury pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Waterbury safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Waterbury, CT?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Waterbury?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Waterbury?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Waterbury.

Paid clinical trials near Waterbury

Other metros within reach

New Haven, CT1,178 Bridgeport, CT1,449 Hartford, CT437 Danbury, CT1,160 Springfield, MA315 Poughkeepsie, NY78 Norwich, CT115 Yonkers, NY4,161

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Waterbury Bladder Issues Due To Spinal Cord Injury in Waterbury All conditions

More of CT

Bridgeport1,449 New Haven1,178 Danbury1,160 Hartford437 Norwich115

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts